Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Proteasome 26S subunit, ATPase 1 pseudogene 7 (PSMC1P7) is classified as a **pseudogene**, meaning it resembles a protein-coding gene but is not known to produce a functional protein product. Located on human chromosome 3, PSMC1P7 is annotated in multiple gene resources as a non-coding sequence with no reported biological function, disease association, or therapeutic relevance. Unlike the functional protein-coding gene PSMC1, PSMC1P7 does not contribute to proteasome structure or activity and is not a validated drug target or biomarker[1][3][4][6][8]. **Key notes:** - PSMC1P7 is a pseudogene, not an active protein, enzyme, receptor, or any established molecular target[3][4][6][8]. - No associated biological functions or disease roles are documented, nor are there known drugs or mechanisms of action for this locus. - It must be distinguished from the functional proteasome 26S subunit, ATPase 1 (PSMC1), which is biologically active and clinically significant[2][7]. - Its status as a pseudogene and the absence of a functional product make it "incorrect" as a therapeutic or molecular target for drug development or research purposes[6][8].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Proteasome 26S subunit, ATPase 1 pseudogene 7 (PSMC1P7).